Gene editing technology combined with stem cells provides a powerful new way to study genetic kidney diseases and their treatments.
Melbourne researchers have used mini-kidney ‘organoids’ grown in the lab to unravel the mystery of why Mainzer-Saldino syndrome, a rare disease involving a single defective gene, causes life-threatening kidney damage. In doing so, they’ve proven an approach that can be used to study a whole range of other genetic kidney diseases. Continue reading Mini-kidneys tell two sides of a genetic story→
Dr Suetonia Palmer is challenging the status quo for kidney disease treatment and helping millions of people with chronic kidney disease take back control of their lives.
Working from temporary facilities as Christchurch rebuilds, she is guiding doctors and policy makers across the world as they attempt to make the best decisions for their patients.